• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲健康数据空间在传染病监测以及药品和疫苗监测方面:一个考察用户体验的试点项目的成果

The European Health Data Space in communicable diseases surveillance and monitoring of medicines and vaccines: achievements of a pilot project examining the user journey.

作者信息

Schneider Katharina L, Alves de Sousa Luís, Sava Ionut, Heß Steffen, Umuhire Denise, Morales Daniel R

机构信息

Data Access and Coordination Office, Federal Institute for Drugs and Medical Devices, Bonn, Germany.

European Centre for Disease Prevention and Control, Stockholm, Sweden.

出版信息

Eur J Public Health. 2025 Sep 1;35(Supplement_3):iii5-iii10. doi: 10.1093/eurpub/ckaf115.

DOI:10.1093/eurpub/ckaf115
PMID:40926480
Abstract

The future European Health Data Space (EHDS), a network for secure cross-border data use, could be beneficial for public health initiatives. The HealthData@EU pilot project evaluated possibilities of secondary data use based on five use cases and established a pilot IT infrastructure. This article reports overarching experiences from two public health use cases and the IT development. Experiences were reported by the Users' Journey steps (data discovery, application, use, and finalization) elaborated in the context of the European Health Data Space (TEHDAS), the first conceptual EHDS project. The European Medicines Agency's use case analysed coagulopathy-related events in COVID-19 patients, the one led by the European Centre for Disease Prevention and Control assessed the feasibility of HealthData@EU to support antimicrobial resistance surveillance. The IT work package developed the infrastructure for information exchange. The use cases indicated that standardized procedures, wherever available, were considered highly beneficial. In the application phase, node-specific requirements slowed down the progress. A distributed approach in combination with the use of Secure Processing Environments (SPE) was successfully conducted. The IT infrastructure was piloted, tested, and published as open source. It supports data discovery and applications in the future. The HealthData@EU pilot project has achieved major steps regarding data discoverability and accessibility, where a need for more standardized procedures was detected in the use cases. Distributed analyses in combination with SPE use may be possible approaches for the data use phase, which require further investigation in TEHDAS2 and other initiatives.

摘要

未来的欧洲健康数据空间(EHDS)是一个用于安全跨境数据使用的网络,可能对公共卫生倡议有益。“欧盟健康数据”试点项目基于五个用例评估了二次数据使用的可能性,并建立了一个试点IT基础设施。本文报告了两个公共卫生用例和IT开发方面的总体经验。经验是根据在欧洲健康数据空间(TEHDAS)(第一个概念性EHDS项目)背景下阐述的用户旅程步骤(数据发现、应用、使用和完成)报告的。欧洲药品管理局的用例分析了新冠肺炎患者的凝血病相关事件,由欧洲疾病预防控制中心牵头的用例评估了“欧盟健康数据”支持抗菌药物耐药性监测的可行性。IT工作包开发了信息交换基础设施。用例表明,只要有标准化程序,就被认为非常有益。在应用阶段,特定节点的要求减缓了进展。成功实施了一种分布式方法,并结合使用安全处理环境(SPE)。IT基础设施进行了试点、测试并作为开源发布。它支持未来的数据发现和应用。“欧盟健康数据”试点项目在数据可发现性和可访问性方面取得了重大进展,在用例中发现了对更标准化程序的需求。结合使用SPE进行分布式分析可能是数据使用阶段的可行方法,这需要在TEHDAS2和其他倡议中进一步研究。

相似文献

1
The European Health Data Space in communicable diseases surveillance and monitoring of medicines and vaccines: achievements of a pilot project examining the user journey.欧洲健康数据空间在传染病监测以及药品和疫苗监测方面:一个考察用户体验的试点项目的成果
Eur J Public Health. 2025 Sep 1;35(Supplement_3):iii5-iii10. doi: 10.1093/eurpub/ckaf115.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Shaping the future EHDS: recommendations for implementation of Health Data Access Bodies in the HealthData@EU infrastructure for secondary use of electronic health data.塑造未来的欧洲健康数据空间:关于在HealthData@EU基础设施中设立健康数据访问机构以二次使用电子健康数据的实施建议。
Eur J Public Health. 2025 Sep 1;35(Supplement_3):iii32-iii38. doi: 10.1093/eurpub/ckaf033.
4
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
5
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
6
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
7
Optimising cardiac surgery outcomes in people with diabetes: the OCTOPuS pilot feasibility study.优化糖尿病患者心脏手术的预后:OCTOPuS试点可行性研究
Health Technol Assess. 2025 Aug;29(39):1-31. doi: 10.3310/POYW3311.
8
Feasibility of mapping cross-country population coronavirus disease 2019 metrics in a federated design: learnings from a HealthData@EU Pilot use case.在联邦设计中绘制跨国人群2019冠状病毒病指标的可行性:来自HealthData@EU试点用例的经验教训。
Eur J Public Health. 2025 Sep 1;35(Supplement_3):iii11-iii17. doi: 10.1093/eurpub/ckaf017.
9
Post-pandemic planning for maternity care for local, regional, and national maternity systems across the four nations: a mixed-methods study.针对四个地区的地方、区域和国家孕产妇保健系统的疫情后规划:一项混合方法研究。
Health Soc Care Deliv Res. 2025 Sep;13(35):1-25. doi: 10.3310/HHTE6611.
10
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.